OCGN Logo

Ocugen, Inc. (OCGN) 

NASDAQ
Market Cap
$329.41M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
683 of 809
Rank in Industry
374 of 445

Largest Insider Buys in Sector

OCGN Stock Price History Chart

OCGN Stock Performance

About Ocugen, Inc.

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD. Ocugen, Inc. has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing; and Bharat Biotech for the commercialization of COVAXIN in the United States market. The company is headquartered in Malvern, Pennsylvania.

Insider Activity of Ocugen, Inc.

Over the last 12 months, insiders at Ocugen, Inc. have bought $0 and sold $0 worth of Ocugen, Inc. stock.

On average, over the past 5 years, insiders at Ocugen, Inc. have bought $613,890 and sold $9.67M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 200,278 shares for transaction amount of $99,999 was made by Zhang Junge (director) on 2023‑06‑14.

List of Insider Buy and Sell Transactions, Ocugen, Inc.

2023-06-14PurchaseZhang Jungedirector
200,278
0.0886%
$0.50$99,999+8.98%
2023-02-16SaleMusunuri ShankarChief Executive Officer
100,000
0.046%
$1.08$108,000-49.12%
2023-01-17SaleMusunuri ShankarChief Executive Officer
100,000
0.045%
$1.28$128,000-56.90%
2022-12-16SaleMusunuri ShankarChief Executive Officer
95,809
0.0407%
$1.43$137,007-62.61%
2022-10-14SaleMusunuri ShankarChief Executive Officer
100,000
0.0484%
$1.66$166,000-49.17%
2022-10-06SaleKumar Rameshdirector
4,500
0.0021%
$1.83$8,235-54.28%
2022-08-11SaleCastillo Kirsten
42,000
0.0211%
$2.91$122,220-58.40%
2022-07-18SaleKumar Ramesh
7,500
0.0036%
$2.57$19,275-49.19%
2022-07-14SaleMusunuri ShankarChief Executive Officer
150,000
0.0716%
$2.72$408,000-52.09%
2022-05-13SaleMusunuri ShankarChief Executive Officer
125,000
0.0529%
$1.92$240,000-23.33%
2022-04-18SaleKumar Ramesh
7,500
0.0038%
$2.83$21,225-33.85%
2022-03-16SaleMusunuri ShankarChief Executive Officer
81,823
0.0367%
$2.65$216,831-31.01%
2022-02-14SaleMusunuri ShankarChief Executive Officer
90,000
0.045%
$3.74$336,600-39.01%
2022-01-18SaleKumar Rameshdirector
7,500
0.0037%
$4.07$30,525-41.25%
2021-12-16SaleMusunuri ShankarChief Executive Officer
115,000
0.0613%
$5.22$600,300-50.70%
2021-11-16SaleMusunuri ShankarChief Executive Officer
115,000
0.0583%
$8.04$924,600-67.77%
2021-11-03SaleZhang Jungedirector
150,300
0.1049%
$17.32$2.6M-79.03%
2021-11-02SaleZhang Jungedirector
149,700
0.0772%
$15.75$2.36M-82.93%
2021-11-02SaleKompella Udaydirector
25,000
0.0131%
$16.01$400,250-82.93%
2021-11-02SaleCastillo Kirstendirector
15,000
0.0074%
$15.00$225,000-82.93%

Insider Historical Profitability

<0.0001%
Lewis Michael
3610570
1.4076%
$1.2821
Wilmslow Estates Ltd10 percent owner
3610570
1.4076%
$1.2821
Musunuri ShankarChief Executive Officer
2190073
0.8538%
$1.28216<0.0001%
Sofinnova Venture Partners VIII, L.P.10 percent owner
2085848
0.8132%
$1.2811
KIRK RANDAL J10 percent owner
1692366
0.6598%
$1.2803
SPLIT ROCK PARTNERS II, LP10 percent owner
1661495
0.6478%
$1.2821<0.0001%
Zhang Jungedirector
1077182
0.42%
$1.2882<0.0001%
RAKIN KEVINdirector
245563
0.0957%
$1.2821
Kompella Udaydirector
154416
0.0602%
$1.28013
Castillo Kirsten
50000
0.0195%
$1.2813+53.85%
Subramanian SanjayChief Financial Officer
35591
0.0139%
$1.2827<0.0001%
Potti Manishdirector
27695
0.0108%
$1.2803
GILL DAVID Ndirector
14000
0.0055%
$1.2840+2.86%
Gridley AdamPresident and CEO
7000
0.0027%
$1.2820<0.0001%
Lieber Jonathan IChief Financial Officer
5000
0.0019%
$1.2810<0.0001%
Kumar Rameshdirector
0
0%
$1.2807
Tammara VijaySenior Vice President
0
0%
$1.2803
Fernandes Prabhavathidirector
0
0%
$1.2801

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$19.68M4.6612M-0.34%-$66,201.88<0.0001
BlackRock$6.23M1.483.8M+2.87%+$173,772.77<0.0001
Geode Capital Management$5.27M1.253.21M+9.68%+$465,155.34<0.0001
Goldman Sachs$4.28M1.012.61MNew+$4.28M<0.01
Millennium Management LLC$3.16M0.751.93M+368.6%+$2.48M<0.01
Susquehanna International Group$1.96M0.471.2M+246.39%+$1.4M<0.01
Two Sigma$1.68M0.41.03M+552.25%+$1.42M<0.01
State Street$1.57M0.37956,726+14.46%+$198,276.05<0.0001
Hrt Financial Llc$1.32M0.31806,500New+$1.32M0.01
Group One Trading$1.02M0.24624,796+24.45%+$201,301.710.03
Morgan Stanley$1.02M0.24619,405+109.14%+$530,106.94<0.0001
Northern Trust$835,280.000.2509,317-0.09%-$708.48<0.0001
JPMorgan Chase$642,757.000.15391,925+114.39%+$342,943.68<0.0001
Point72 Asia Singapore Pte Ltd$601,782.000.14366,940+1,322.25%+$559,469.970.06
Bank of America$449,005.000.11273,783+76.43%+$194,507.66<0.0001
Jane Street Capital$328,505.000.08200,308+1,418.98%+$306,878.33<0.0001
T. Rowe Price$307,000.000.07187,1000%+$0<0.0001
Simplex Trading Llc$305,000.000.07186,557+207.82%+$205,915.910.01
Charles Schwab$279,217.000.07170,2540%+$0<0.0001
Squarepoint Ops LLC$235,165.000.06143,393New+$235,165.00<0.01
Y Intercept Hong Kong Ltd$211,273.000.05128,825New+$211,273.000.01
Fidelity Investments$200,242.000.05122,099+3.12%+$6,049.95<0.0001
Balyasny Asset Management Llc$181,771.000.04110,836New+$181,771.00<0.0001
State Board of Administration of Florida$68,825.000.0380,676New+$68,825.00<0.0001
Advisor Group Holdings Inc$124,698.000.0376,036+126.86%+$69,732.22<0.0001
TWO SIGMA SECURITIES LLC$117,181.000.0371,452+133.7%+$67,039.76<0.01
Brevan Howard Capital Management Lp$113,600.000.0369,268New+$113,600.000.01
Toroso Investments Llc$108,255.000.0366,009New+$108,255.00<0.0001
OMERS$110,536.000.0367,400New+$110,536.00<0.01
CAPTRUST$98,400.000.0260,0000%+$0<0.0001
LAZARD ASSET MANAGEMENT LLC$69,000.000.0243,019-35.56%-$38,082.40<0.0001
Headlands Technologies Llc$65,925.000.0240,198New+$65,925.000.01
Verition Fund Management Llc$49,200.000.0130,000-92.5%-$606,800.00<0.01
Citigroup$41,128.000.0125,078+15,191.46%+$40,859.04<0.0001
BNY Mellon$43,103.000.0126,283-70.05%-$100,806.54<0.0001
DRW Securities LLC$39,688.000.0124,200New+$39,688.00<0.01
Lanham O Dell Company Inc$37,802.000.0123,050+108.6%+$19,680.00<0.01
Baldwin Management$36,900.000.0122,5000%+$00.01
Wolverine Trading$38,586.000.0123,528New+$38,586.00<0.0001
David J Yvars Group$34,719.000.0121,170New+$34,719.000.02
Raleigh Capital Management Inc$32,800.000.0120,000New+$32,800.000.02
Truefg LLC$34,440.000.0121,000New+$34,440.000.01
Thrivent Financial For Lutherans$33,000.000.0120,0000%+$0<0.0001
Just Invest, LLC$30,602.000.0118,6600%+$0<0.01
Raymond James Associates$29,684.000.0118,100New+$29,684.00<0.0001
Wedmont Private Capital$25,248.000.0114,765New+$25,248.00<0.01
Symmetry Investments Lp$25,000.000.0115,000New+$25,000.00<0.01
UBS$23,262.000.0114,184+272.77%+$17,021.74<0.0001
Tower Research Capital$24,063.000.0114,672+3,568%+$23,406.97<0.0001
Perennial Investment Advisors Llc$24,600.000.0115,0000%+$0<0.01